Associations between Early Markers of Parkinson's Disease and Sarcopenia
Michael Drey(LMU Klinikum), Walter Maetzler(Centre Hospitalier Universitaire de Lille), Morad Elshehabi(University Hospital Schleswig-Holstein), Markus A. Hobert(University Hospital Schleswig-Holstein), Anna‐Katharina von Thaler(Christian-Albrechts-Universität zu Kiel), Jan-Peter Krenovsky(LMU Klinikum), Ulrike Suenkel(Hertie Institute for Clinical Brain Research), Sandra E. Hasmann(Hertie Institute for Clinical Brain Research), Andreas J. Fallgatter(University of Würzburg), Daniela Berg(Christian-Albrechts-Universität zu Kiel), Stefanie Straub(Hertie Institute for Clinical Brain Research), Gerhard W. Eschweiler(University Children's Hospital Tübingen)
Cited by 65
Related Papers
MDS clinical diagnostic criteria for Parkinson's disease
|Movement Disorders|2015|7.4k
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
|New England Journal of Medicine|2009|2.1k
Genome-wide association study reveals genetic risk underlying Parkinson's disease
|Nature Genetics|2009|2k
MDS research criteria for prodromal Parkinson's disease
|Movement Disorders|2015|1.3k
Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy
|Movement Disorders|2017|846